Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...

Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

Tharimmune, Inc. (NASDAQ:THAR) shares are moving higher Wednesday after the company announced it received overall positive ...

2 Common symptoms like fatigue and pruritus (chronic itch) are sometimes misdiagnosed as conditions like atopic dermatitis or psoriasis, causing delays in diagnosis and suitable treatment.

New research reveals itchiness may be a defense mechanism, with persistent pruritus serving as the skin’s early alarm against ...

Having an itch that you just can’t scratch is one of the most frustrating experiences – but it might actually be beneficial ...

In the three aforementioned studies of epidural delivery of naloxone in combination with an opioid (fentanyl or morphine), the frequency of pruritus was decreased, with no reversal of analgesia noted.

Significant progress is being made in the fight against Chronic Kidney Disease-associated Pruritus but sustaining strong ...

TH104, the Company's lead candidate for moderate-to-severe pruritus in chronic liver disease, showed no opioid withdrawal ...

Charting, Price Performance, News & Related Contracts.